Tumour-necrosis-factor antibody treatment in Crohn's disease.
Derkx
B
B
Taminiau
J
J
Radema
S
S
Stronkhorst
A
A
Wortel
C
C
Tytgat
G
G
van Deventer
S
S
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D003424:Crohn Disease / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D019804:Mesalamine; D011241:Prednisone / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000636:Aminosalicylic Acids; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D019804:Mesalamine; D001379:Azathioprine; D011241:Prednisone